Skip to main content
Log in

CBT may be cost effective in certain patients for pharmacotherapy-resistant depression in Japan

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. Maudsley Staging Method score of ≥3 and a 17-item GRID-Hamilton Depression Rating Scale score of ≥16.

Reference

  • Sado M, et al. Cost-effectiveness analyses of augmented cognitive behavioral therapy for pharmacotherapy-resistant depression at secondary mental health care settings. Psychiatry and Clinical Neurosciences : 29 Aug 2021. Available from: URL: http://doi.org/10.1111/pcn.13298

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

CBT may be cost effective in certain patients for pharmacotherapy-resistant depression in Japan. PharmacoEcon Outcomes News 887, 10 (2021). https://doi.org/10.1007/s40274-021-08026-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-08026-2

Navigation